3,4-dihydroxyphenylglycol has been researched along with Multiple System Atrophy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, DS; Holmes, C; Lamotte, G; Lenka, A; Sharabi, Y; Sullivan, P | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Sharabi, Y | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Mash, DC; Sharabi, Y; Sullivan, P | 1 |
| Goldstein, DS; Holmes, C; Sharabi, Y | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Patronas, N | 1 |
| Bruce, S; Cannon, RO; Goldstein, DS; Holmes, C; Li, ST; Metman, LV | 1 |
6 other study(ies) available for 3,4-dihydroxyphenylglycol and Multiple System Atrophy
| Article | Year |
|---|---|
Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Cohort Studies; Dopamine; Dopaminergic Neurons; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Neurons; Norepinephrine; Parkinson Disease; Pure Autonomic Failure; Retrospective Studies; Synucleinopathies | 2021 |
Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Diagnosis, Differential; Dopamine; Female; Fluorine Radioisotopes; Humans; Hypotension, Orthostatic; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinson Disease; Sensitivity and Specificity; Synaptic Vesicles | 2015 |
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Aldehyde Dehydrogenase; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Humans; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Neurons; Norepinephrine; Parkinson Disease | 2015 |
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Catecholamines; Dopamine Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Pure Autonomic Failure; ROC Curve | 2012 |
Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension.
Topics: Aged; Alzheimer Disease; Autonomic Nervous System Diseases; Case-Control Studies; Catechols; Chronic Disease; Humans; Hypotension, Orthostatic; Linear Models; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Norepinephrine | 2003 |
Cardiac sympathetic denervation in Parkinson disease.
Topics: Adult; Aged; Blood Pressure; Brain; Cardiac Catheterization; Diagnosis, Differential; Dopamine; Female; Fluorine Radioisotopes; Heart; Heart Rate; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Myocardium; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tritium; Valsalva Maneuver | 2000 |